Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular validation of the schizophrenia spectrum.

Schizophrenia bulletin - 1 Jan 2014

Bigdeli T Bernard, Bacanu Silviu-Alin, Webb Bradley T, Walsh Dermot, O'Neill F Anthony, Fanous Ayman H, Riley Brien P, Kendler Kenneth S

Abstract excerpt

BACKGROUND: Early descriptive work and controlled family and adoption studies support the hypothesis that a range of personality and nonschizophrenic psychotic disorders aggregate in families of schizophrenic probands. Can we validate, using molecular polygene scores from genome-wide association...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genome-Wide Association Study
Share to Ireland
Share to Multifactorial Inheritance

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Northern Ireland

Share to Pedigree

Share to Polymorphism, Single Nucleotide

Share to Predictive Value of Tests

Share to Schizophrenia

Source

Open in PubMed Open full text

Identifiers

PMID: 23970557
DOI: 10.1093/schbul/sbt122
PMCID: PMC3885304

Genes

PGC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23970557-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular validation of the schizophrenia spectrum.PMID 23970557Read ↗

Genome-wide association study reveals greater polygenic loading for schizophrenia in cases with a family history of illness.Semantic proximity Read ↗

Penetrance and pleiotropy of polygenic risk scores for schizophrenia in 106,160 patients across four healthcare systemsSemantic proximity Read ↗

Use of schizophrenia and bipolar disorder polygenic risk scores to identify psychotic disorders.Semantic proximity Read ↗

Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample; the EU-GEI study.Semantic proximity Read ↗

Pathway-based polygenic risk scores for schizophrenia and associations with clinical and neuroimaging phenotypes in UK BiobankSemantic proximity Read ↗

Use of multiple Polygenic Risk Scores for distinguishing Schizophrenia-spectrum disorder and Affective psychosis categories; the EUGEI studySemantic proximity Read ↗

Research review: Polygenic methods and their application to psychiatric traits.Semantic proximity Read ↗

Transdiagnostic Effects of Schizophrenia Polygenic Scores on Treatment Outcomes in Major Psychiatric DisordersSemantic proximity Read ↗

Polygenic Risk Scores in Clinical Psychology: Bridging Genomic Risk to Individual Differences.Semantic proximity Read ↗

Polygenic risk score and the psychosis continuum model.Semantic proximity Read ↗

Polygenic risk scores across the extended psychosis spectrum.Semantic proximity Read ↗

Pathway-Specific Polygenic Scores Improve Cross-Ancestry Prediction of Psychosis and Clinical OutcomesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.